[抗精神病药物与中枢兴奋剂结合使用]
Martin Jacobsen1, Niels August Willer Strand1, Søren Bøgevig2
1Enhed for Kompliceret Skizofreni, Psykiatrisk Center Glostrup, Region Hovedstadens Psykiatri.
Ugeskrift for laeger
|November 20, 2025
概括
本综述详细介绍了管理中枢刺激剂 (CS) 引起的急性中毒以及在同时暴露的患者中适当使用抗精神病药物 (AP) 的方法. 它为临床医生提供了处理这些复杂临床情景的指导.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
- 毒理学 毒理学 毒理学
背景情况:
- 中央兴奋剂 (CS) 和抗精神病药物 (AP) 经常在临床环境中同时使用或共同摄入.
- 由于复杂的药物相互作用和重叠的毒性,管理暴露于CS和AP的患者存在独特的挑战.
研究的目的:
- 提供对目前对CS急性中毒的管理策略的全面概述.
- 概述在同时暴露于CS的患者中AP的管理和管理的最佳实践.
- 解决不同患者群体中对CS和AP共同暴露的复杂性.
主要方法:
- 本综述综合了当前的文献和临床指南.
- 精神病学家,临床药理学家和麻醉学家之间的专家合作确保了多学科的方法.
- 该审查侧重于临床场景的最新管理,包括同时暴露于CS和AP.
主要成果:
- 该审查详细介绍了急性CS中毒的治疗方案.
- 它提供了基于患者群体和暴露水平的AP管理的具体建议.
- 这些发现强调了协调,多学科方法的重要性.
结论:
- 有效管理CS中毒需要仔细考虑并发AP使用.
- 涉及各种医学专家的协作方法对于优化患者的治疗结果至关重要.
- 本综述是临床医生管理复杂的共同暴露病例的宝贵资源.
相关概念视频
01:23Drugs Acting on Autonomic Ganglia: Stimulants
2.0K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.0K
01:28Psychosis and Antipsychotic Drugs: Overview
786
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
786
01:24Parkinson's Disease: Treatment
953
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
953
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
747
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
747
01:28Drug Therapy
235
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
235
01:22CNS Stimulants: Psychedelic Agents
645
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
645